Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:muscimol'
(id=6731385 ; fe=en:muscimol ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=3439 creation date=2017-06-21 touchdate=2025-12-15 14:46:34.000)
≈ 84 relations sortantes

  1. en:muscimol -- r_associated #0: 42 / 1 -> en:oxazolone
    n1=en:muscimol | n2=en:oxazolone | rel=r_associated | relid=0 | w=42
  2. en:muscimol -- r_associated #0: 40 / 0.952 -> en:antidepressant agent
    n1=en:muscimol | n2=en:antidepressant agent | rel=r_associated | relid=0 | w=40
  3. en:muscimol -- r_associated #0: 38 / 0.905 -> en:alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
    n1=en:muscimol | n2=en:alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | rel=r_associated | relid=0 | w=38
  4. en:muscimol -- r_associated #0: 38 / 0.905 -> en:amanitins
    n1=en:muscimol | n2=en:amanitins | rel=r_associated | relid=0 | w=38
  5. en:muscimol -- r_associated #0: 35 / 0.833 -> en:antitussive agent
    n1=en:muscimol | n2=en:antitussive agent | rel=r_associated | relid=0 | w=35
  6. en:muscimol -- r_associated #0: 35 / 0.833 -> en:central nervous system depressants
    n1=en:muscimol | n2=en:central nervous system depressants | rel=r_associated | relid=0 | w=35
  7. en:muscimol -- r_associated #0: 35 / 0.833 -> en:ibotenic acid
    n1=en:muscimol | n2=en:ibotenic acid | rel=r_associated | relid=0 | w=35
  8. en:muscimol -- r_associated #0: 35 / 0.833 -> en:muscle relaxants, central
    n1=en:muscimol | n2=en:muscle relaxants, central | rel=r_associated | relid=0 | w=35
  9. en:muscimol -- r_associated #0: 35 / 0.833 -> en:nootropic agents
    n1=en:muscimol | n2=en:nootropic agents | rel=r_associated | relid=0 | w=35
  10. en:muscimol -- r_associated #0: 34 / 0.81 -> en:cns medications,other
    n1=en:muscimol | n2=en:cns medications,other | rel=r_associated | relid=0 | w=34
  11. en:muscimol -- r_associated #0: 34 / 0.81 -> en:pemoline
    n1=en:muscimol | n2=en:pemoline | rel=r_associated | relid=0 | w=34
  12. en:muscimol -- r_associated #0: 34 / 0.81 -> en:t-2 toxin
    n1=en:muscimol | n2=en:t-2 toxin | rel=r_associated | relid=0 | w=34
  13. en:muscimol -- r_associated #0: 32 / 0.762 -> en:cns stimulant
    n1=en:muscimol | n2=en:cns stimulant | rel=r_associated | relid=0 | w=32
  14. en:muscimol -- r_associated #0: 32 / 0.762 -> en:fumonisin b1
    n1=en:muscimol | n2=en:fumonisin b1 | rel=r_associated | relid=0 | w=32
  15. en:muscimol -- r_associated #0: 32 / 0.762 -> en:fura-2
    n1=en:muscimol | n2=en:fura-2 | rel=r_associated | relid=0 | w=32
  16. en:muscimol -- r_associated #0: 32 / 0.762 -> en:sporidesmins
    n1=en:muscimol | n2=en:sporidesmins | rel=r_associated | relid=0 | w=32
  17. en:muscimol -- r_associated #0: 31 / 0.738 -> en:aflatoxin
    n1=en:muscimol | n2=en:aflatoxin | rel=r_associated | relid=0 | w=31
  18. en:muscimol -- r_associated #0: 31 / 0.738 -> en:aminorex
    n1=en:muscimol | n2=en:aminorex | rel=r_associated | relid=0 | w=31
  19. en:muscimol -- r_associated #0: 31 / 0.738 -> en:isocarboxazid
    n1=en:muscimol | n2=en:isocarboxazid | rel=r_associated | relid=0 | w=31
  20. en:muscimol -- r_associated #0: 31 / 0.738 -> en:leflunomide
    n1=en:muscimol | n2=en:leflunomide | rel=r_associated | relid=0 | w=31
  21. en:muscimol -- r_associated #0: 31 / 0.738 -> en:phalloidine
    n1=en:muscimol | n2=en:phalloidine | rel=r_associated | relid=0 | w=31
  22. en:muscimol -- r_associated #0: 30 / 0.714 -> en:analgesic agent
    n1=en:muscimol | n2=en:analgesic agent | rel=r_associated | relid=0 | w=30
  23. en:muscimol -- r_associated #0: 30 / 0.714 -> en:anguidine
    n1=en:muscimol | n2=en:anguidine | rel=r_associated | relid=0 | w=30
  24. en:muscimol -- r_associated #0: 30 / 0.714 -> en:antiparkinsonian agent
    n1=en:muscimol | n2=en:antiparkinsonian agent | rel=r_associated | relid=0 | w=30
  25. en:muscimol -- r_associated #0: 30 / 0.714 -> en:cytochalasins
    n1=en:muscimol | n2=en:cytochalasins | rel=r_associated | relid=0 | w=30
  26. en:muscimol -- r_associated #0: 30 / 0.714 -> en:dihydroergocornine
    n1=en:muscimol | n2=en:dihydroergocornine | rel=r_associated | relid=0 | w=30
  27. en:muscimol -- r_associated #0: 30 / 0.714 -> en:opiate antagonist
    n1=en:muscimol | n2=en:opiate antagonist | rel=r_associated | relid=0 | w=30
  28. en:muscimol -- r_associated #0: 30 / 0.714 -> en:tenuazonic acid
    n1=en:muscimol | n2=en:tenuazonic acid | rel=r_associated | relid=0 | w=30
  29. en:muscimol -- r_associated #0: 29 / 0.69 -> en:anti-dyskinesia agents
    n1=en:muscimol | n2=en:anti-dyskinesia agents | rel=r_associated | relid=0 | w=29
  30. en:muscimol -- r_associated #0: 29 / 0.69 -> en:antiemetic agent
    n1=en:muscimol | n2=en:antiemetic agent | rel=r_associated | relid=0 | w=29
  31. en:muscimol -- r_associated #0: 29 / 0.69 -> en:gaba-a receptor
    n1=en:muscimol | n2=en:gaba-a receptor | rel=r_associated | relid=0 | w=29
  32. en:muscimol -- r_associated #0: 29 / 0.69 -> en:ibotenate
    n1=en:muscimol | n2=en:ibotenate | rel=r_associated | relid=0 | w=29
  33. en:muscimol -- r_associated #0: 29 / 0.69 -> en:isomuscimol
    n1=en:muscimol | n2=en:isomuscimol | rel=r_associated | relid=0 | w=29
  34. en:muscimol -- r_associated #0: 29 / 0.69 -> en:muscarine
    n1=en:muscimol | n2=en:muscarine | rel=r_associated | relid=0 | w=29
  35. en:muscimol -- r_associated #0: 29 / 0.69 -> en:paliperidone palmitate
    n1=en:muscimol | n2=en:paliperidone palmitate | rel=r_associated | relid=0 | w=29
  36. en:muscimol -- r_associated #0: 29 / 0.69 -> en:standards characteristics
    n1=en:muscimol | n2=en:standards characteristics | rel=r_associated | relid=0 | w=29
  37. en:muscimol -- r_associated #0: 29 / 0.69 -> en:sterigmatocystin
    n1=en:muscimol | n2=en:sterigmatocystin | rel=r_associated | relid=0 | w=29
  38. en:muscimol -- r_associated #0: 29 / 0.69 -> en:trimethadione
    n1=en:muscimol | n2=en:trimethadione | rel=r_associated | relid=0 | w=29
  39. en:muscimol -- r_associated #0: 28 / 0.667 -> en:anticonvulsant agent
    n1=en:muscimol | n2=en:anticonvulsant agent | rel=r_associated | relid=0 | w=28
  40. en:muscimol -- r_associated #0: 28 / 0.667 -> en:emetic
    n1=en:muscimol | n2=en:emetic | rel=r_associated | relid=0 | w=28
  41. en:muscimol -- r_associated #0: 28 / 0.667 -> en:oxadiazoles
    n1=en:muscimol | n2=en:oxadiazoles | rel=r_associated | relid=0 | w=28
  42. en:muscimol -- r_associated #0: 28 / 0.667 -> en:oxazoles
    n1=en:muscimol | n2=en:oxazoles | rel=r_associated | relid=0 | w=28
  43. en:muscimol -- r_associated #0: 28 / 0.667 -> en:oxazolidinones
    n1=en:muscimol | n2=en:oxazolidinones | rel=r_associated | relid=0 | w=28
  44. en:muscimol -- r_associated #0: 28 / 0.667 -> en:thiomuscimol
    n1=en:muscimol | n2=en:thiomuscimol | rel=r_associated | relid=0 | w=28
  45. en:muscimol -- r_associated #0: 27 / 0.643 -> en:cycloserine
    n1=en:muscimol | n2=en:cycloserine | rel=r_associated | relid=0 | w=27
  46. en:muscimol -- r_associated #0: 26 / 0.619 -> en:antipyretics
    n1=en:muscimol | n2=en:antipyretics | rel=r_associated | relid=0 | w=26
  47. en:muscimol -- r_associated #0: 26 / 0.619 -> en:aspergillin
    n1=en:muscimol | n2=en:aspergillin | rel=r_associated | relid=0 | w=26
  48. en:muscimol -- r_associated #0: 26 / 0.619 -> en:central nervous system agents
    n1=en:muscimol | n2=en:central nervous system agents | rel=r_associated | relid=0 | w=26
  49. en:muscimol -- r_associated #0: 26 / 0.619 -> en:isoxazoles
    n1=en:muscimol | n2=en:isoxazoles | rel=r_associated | relid=0 | w=26
  50. en:muscimol -- r_associated #0: 26 / 0.619 -> en:n,n-dimethylthiomuscimol
    n1=en:muscimol | n2=en:n,n-dimethylthiomuscimol | rel=r_associated | relid=0 | w=26
  51. en:muscimol -- r_associated #0: 24 / 0.571 -> en:tetrabenazine
    n1=en:muscimol | n2=en:tetrabenazine | rel=r_associated | relid=0 | w=24
  52. en:muscimol -- r_associated #0: 23 / 0.548 -> en:therapeutic use - qualifier
    n1=en:muscimol | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=23
  53. en:muscimol -- r_associated #0: 22 / 0.524 -> en:agonists
    n1=en:muscimol | n2=en:agonists | rel=r_associated | relid=0 | w=22
  54. en:muscimol -- r_associated #0: 22 / 0.524 -> en:mechanism of action qualifier
    n1=en:muscimol | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=22
  55. en:muscimol -- r_associated #0: 22 / 0.524 -> en:pharmacokinetic aspects
    n1=en:muscimol | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=22
  56. en:muscimol -- r_associated #0: 22 / 0.524 -> en:sodium oxybate
    n1=en:muscimol | n2=en:sodium oxybate | rel=r_associated | relid=0 | w=22
  57. en:muscimol -- r_associated #0: 21 / 0.5 -> en:paramethadione
    n1=en:muscimol | n2=en:paramethadione | rel=r_associated | relid=0 | w=21
  58. en:muscimol -- r_associated #0: 20 / 0.476 -> anæsthésique
    n1=en:muscimol | n2=anæsthésique | rel=r_associated | relid=0 | w=20
  59. en:muscimol -- r_associated #0: 20 / 0.476 -> anesthésique
    n1=en:muscimol | n2=anesthésique | rel=r_associated | relid=0 | w=20
  60. en:muscimol -- r_associated #0: 20 / 0.476 -> antagoniste des morphiniques
    n1=en:muscimol | n2=antagoniste des morphiniques | rel=r_associated | relid=0 | w=20
  61. en:muscimol -- r_associated #0: 20 / 0.476 -> dihydroergocornine
    n1=en:muscimol | n2=dihydroergocornine | rel=r_associated | relid=0 | w=20
  62. en:muscimol -- r_associated #0: 20 / 0.476 -> émétisante
    n1=en:muscimol | n2=émétisante | rel=r_associated | relid=0 | w=20
  63. en:muscimol -- r_associated #0: 20 / 0.476 -> en:amatoxin
    n1=en:muscimol | n2=en:amatoxin | rel=r_associated | relid=0 | w=20
  64. en:muscimol -- r_associated #0: 20 / 0.476 -> en:anesthetic agent
    n1=en:muscimol | n2=en:anesthetic agent | rel=r_associated | relid=0 | w=20
  65. en:muscimol -- r_associated #0: 20 / 0.476 -> en:anti-obesity agents
    n1=en:muscimol | n2=en:anti-obesity agents | rel=r_associated | relid=0 | w=20
  66. en:muscimol -- r_associated #0: 20 / 0.476 -> en:central nervous system, other
    n1=en:muscimol | n2=en:central nervous system, other | rel=r_associated | relid=0 | w=20
  67. en:muscimol -- r_associated #0: 20 / 0.476 -> en:drugs used in neuropathic pain
    n1=en:muscimol | n2=en:drugs used in neuropathic pain | rel=r_associated | relid=0 | w=20
  68. en:muscimol -- r_associated #0: 20 / 0.476 -> en:excitatory amino acid antagonists
    n1=en:muscimol | n2=en:excitatory amino acid antagonists | rel=r_associated | relid=0 | w=20
  69. en:muscimol -- r_associated #0: 20 / 0.476 -> en:gaba agonists
    n1=en:muscimol | n2=en:gaba agonists | rel=r_associated | relid=0 | w=20
  70. en:muscimol -- r_associated #0: 20 / 0.476 -> en:gyromitrin
    n1=en:muscimol | n2=en:gyromitrin | rel=r_associated | relid=0 | w=20
  71. en:muscimol -- r_associated #0: 20 / 0.476 -> en:idebenone
    n1=en:muscimol | n2=en:idebenone | rel=r_associated | relid=0 | w=20
  72. en:muscimol -- r_associated #0: 20 / 0.476 -> en:mycotoxin
    n1=en:muscimol | n2=en:mycotoxin | rel=r_associated | relid=0 | w=20
  73. en:muscimol -- r_associated #0: 20 / 0.476 -> en:neuroprotective agent
    n1=en:muscimol | n2=en:neuroprotective agent | rel=r_associated | relid=0 | w=20
  74. en:muscimol -- r_associated #0: 20 / 0.476 -> en:neurotoxic mycotoxin
    n1=en:muscimol | n2=en:neurotoxic mycotoxin | rel=r_associated | relid=0 | w=20
  75. en:muscimol -- r_associated #0: 20 / 0.476 -> en:oxazolidone
    n1=en:muscimol | n2=en:oxazolidone | rel=r_associated | relid=0 | w=20
  76. en:muscimol -- r_associated #0: 20 / 0.476 -> en:psilocin
    n1=en:muscimol | n2=en:psilocin | rel=r_associated | relid=0 | w=20
  77. en:muscimol -- r_associated #0: 20 / 0.476 -> en:psychotropic agent
    n1=en:muscimol | n2=en:psychotropic agent | rel=r_associated | relid=0 | w=20
  78. en:muscimol -- r_associated #0: 20 / 0.476 -> en:sodium phenylbutyrate
    n1=en:muscimol | n2=en:sodium phenylbutyrate | rel=r_associated | relid=0 | w=20
  79. en:muscimol -- r_associated #0: 20 / 0.476 -> en:tremorgenic mycotoxin
    n1=en:muscimol | n2=en:tremorgenic mycotoxin | rel=r_associated | relid=0 | w=20
  80. en:muscimol -- r_associated #0: 20 / 0.476 -> mycotoxine
    n1=en:muscimol | n2=mycotoxine | rel=r_associated | relid=0 | w=20
  81. en:muscimol -- r_associated #0: 20 / 0.476 -> mycotoxines
    n1=en:muscimol | n2=mycotoxines | rel=r_associated | relid=0 | w=20
  82. en:muscimol -- r_associated #0: 20 / 0.476 -> produit anesthésiant
    n1=en:muscimol | n2=produit anesthésiant | rel=r_associated | relid=0 | w=20
  83. en:muscimol -- r_associated #0: 20 / 0.476 -> psilocine
    n1=en:muscimol | n2=psilocine | rel=r_associated | relid=0 | w=20
  84. en:muscimol -- r_associated #0: 20 / 0.476 -> toxines fongiques
    n1=en:muscimol | n2=toxines fongiques | rel=r_associated | relid=0 | w=20
≈ 105 relations entrantes

  1. en:anesthetic agent --- r_associated #0: 177 --> en:muscimol
    n1=en:anesthetic agent | n2=en:muscimol | rel=r_associated | relid=0 | w=177
  2. produit anesthésiant --- r_associated #0: 171 --> en:muscimol
    n1=produit anesthésiant | n2=en:muscimol | rel=r_associated | relid=0 | w=171
  3. anesthésique --- r_associated #0: 150 --> en:muscimol
    n1=anesthésique | n2=en:muscimol | rel=r_associated | relid=0 | w=150
  4. en:psilocin --- r_associated #0: 81 --> en:muscimol
    n1=en:psilocin | n2=en:muscimol | rel=r_associated | relid=0 | w=81
  5. mycotoxine --- r_associated #0: 81 --> en:muscimol
    n1=mycotoxine | n2=en:muscimol | rel=r_associated | relid=0 | w=81
  6. psilocine --- r_associated #0: 80 --> en:muscimol
    n1=psilocine | n2=en:muscimol | rel=r_associated | relid=0 | w=80
  7. en:mycotoxin --- r_associated #0: 77 --> en:muscimol
    n1=en:mycotoxin | n2=en:muscimol | rel=r_associated | relid=0 | w=77
  8. anæsthésique --- r_associated #0: 54 --> en:muscimol
    n1=anæsthésique | n2=en:muscimol | rel=r_associated | relid=0 | w=54
  9. en:dihydroergocornine --- r_associated #0: 47 --> en:muscimol
    n1=en:dihydroergocornine | n2=en:muscimol | rel=r_associated | relid=0 | w=47
  10. dihydroergocornine --- r_associated #0: 46 --> en:muscimol
    n1=dihydroergocornine | n2=en:muscimol | rel=r_associated | relid=0 | w=46
  11. en:emetic --- r_associated #0: 46 --> en:muscimol
    n1=en:emetic | n2=en:muscimol | rel=r_associated | relid=0 | w=46
  12. en:paramethadione --- r_associated #0: 42 --> en:muscimol
    n1=en:paramethadione | n2=en:muscimol | rel=r_associated | relid=0 | w=42
  13. agent neuroprotecteur --- r_associated #0: 41 --> en:muscimol
    n1=agent neuroprotecteur | n2=en:muscimol | rel=r_associated | relid=0 | w=41
  14. en:drugs used in neuropathic pain --- r_associated #0: 39 --> en:muscimol
    n1=en:drugs used in neuropathic pain | n2=en:muscimol | rel=r_associated | relid=0 | w=39
  15. en:pemoline --- r_associated #0: 38 --> en:muscimol
    n1=en:pemoline | n2=en:muscimol | rel=r_associated | relid=0 | w=38
  16. en:neuroprotective agent --- r_associated #0: 37 --> en:muscimol
    n1=en:neuroprotective agent | n2=en:muscimol | rel=r_associated | relid=0 | w=37
  17. émétisante --- r_associated #0: 37 --> en:muscimol
    n1=émétisante | n2=en:muscimol | rel=r_associated | relid=0 | w=37
  18. en:amatoxin --- r_associated #0: 35 --> en:muscimol
    n1=en:amatoxin | n2=en:muscimol | rel=r_associated | relid=0 | w=35
  19. en:isomuscimol --- r_associated #0: 35 --> en:muscimol
    n1=en:isomuscimol | n2=en:muscimol | rel=r_associated | relid=0 | w=35
  20. mycotoxines --- r_associated #0: 35 --> en:muscimol
    n1=mycotoxines | n2=en:muscimol | rel=r_associated | relid=0 | w=35
  21. en:fura-2 --- r_associated #0: 34 --> en:muscimol
    n1=en:fura-2 | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  22. en:gaba-a receptor --- r_associated #0: 34 --> en:muscimol
    n1=en:gaba-a receptor | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  23. en:psychotropic agent --- r_associated #0: 34 --> en:muscimol
    n1=en:psychotropic agent | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  24. en:sodium oxybate --- r_associated #0: 34 --> en:muscimol
    n1=en:sodium oxybate | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  25. en:sodium phenylbutyrate --- r_associated #0: 34 --> en:muscimol
    n1=en:sodium phenylbutyrate | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  26. en:standards characteristics --- r_associated #0: 34 --> en:muscimol
    n1=en:standards characteristics | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  27. en:sterigmatocystin --- r_associated #0: 34 --> en:muscimol
    n1=en:sterigmatocystin | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  28. en:therapeutic use - qualifier --- r_associated #0: 34 --> en:muscimol
    n1=en:therapeutic use - qualifier | n2=en:muscimol | rel=r_associated | relid=0 | w=34
  29. en:agonists --- r_associated #0: 32 --> en:muscimol
    n1=en:agonists | n2=en:muscimol | rel=r_associated | relid=0 | w=32
  30. en:central nervous system agents --- r_associated #0: 32 --> en:muscimol
    n1=en:central nervous system agents | n2=en:muscimol | rel=r_associated | relid=0 | w=32
  31. en:opiate antagonist --- r_associated #0: 32 --> en:muscimol
    n1=en:opiate antagonist | n2=en:muscimol | rel=r_associated | relid=0 | w=32
  32. en:pharmacokinetic aspects --- r_associated #0: 32 --> en:muscimol
    n1=en:pharmacokinetic aspects | n2=en:muscimol | rel=r_associated | relid=0 | w=32
  33. en:aspergillin --- r_associated #0: 31 --> en:muscimol
    n1=en:aspergillin | n2=en:muscimol | rel=r_associated | relid=0 | w=31
  34. en:central nervous system, other --- r_associated #0: 31 --> en:muscimol
    n1=en:central nervous system, other | n2=en:muscimol | rel=r_associated | relid=0 | w=31
  35. en:idebenone --- r_associated #0: 31 --> en:muscimol
    n1=en:idebenone | n2=en:muscimol | rel=r_associated | relid=0 | w=31
  36. en:oxazolidone --- r_associated #0: 31 --> en:muscimol
    n1=en:oxazolidone | n2=en:muscimol | rel=r_associated | relid=0 | w=31
  37. en:central nervous system depressants --- r_associated #0: 30 --> en:muscimol
    n1=en:central nervous system depressants | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  38. en:fumonisin b1 --- r_associated #0: 30 --> en:muscimol
    n1=en:fumonisin b1 | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  39. en:ibotenate --- r_associated #0: 30 --> en:muscimol
    n1=en:ibotenate | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  40. en:muscle relaxants, central --- r_associated #0: 30 --> en:muscimol
    n1=en:muscle relaxants, central | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  41. en:oxazolone --- r_associated #0: 30 --> en:muscimol
    n1=en:oxazolone | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  42. en:paliperidone palmitate --- r_associated #0: 30 --> en:muscimol
    n1=en:paliperidone palmitate | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  43. en:sporidesmins --- r_associated #0: 30 --> en:muscimol
    n1=en:sporidesmins | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  44. en:thiomuscimol --- r_associated #0: 30 --> en:muscimol
    n1=en:thiomuscimol | n2=en:muscimol | rel=r_associated | relid=0 | w=30
  45. en:anticonvulsant agent --- r_associated #0: 29 --> en:muscimol
    n1=en:anticonvulsant agent | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  46. en:antiemetic agent --- r_associated #0: 29 --> en:muscimol
    n1=en:antiemetic agent | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  47. en:excitatory amino acid antagonists --- r_associated #0: 29 --> en:muscimol
    n1=en:excitatory amino acid antagonists | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  48. en:isocarboxazid --- r_associated #0: 29 --> en:muscimol
    n1=en:isocarboxazid | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  49. en:isoxazoles --- r_associated #0: 29 --> en:muscimol
    n1=en:isoxazoles | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  50. en:leflunomide --- r_associated #0: 29 --> en:muscimol
    n1=en:leflunomide | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  51. en:tetrabenazine --- r_associated #0: 29 --> en:muscimol
    n1=en:tetrabenazine | n2=en:muscimol | rel=r_associated | relid=0 | w=29
  52. antagoniste des morphiniques --- r_associated #0: 28 --> en:muscimol
    n1=antagoniste des morphiniques | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  53. en:aminorex --- r_associated #0: 28 --> en:muscimol
    n1=en:aminorex | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  54. en:analgesic agent --- r_associated #0: 28 --> en:muscimol
    n1=en:analgesic agent | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  55. en:anti-dyskinesia agents --- r_associated #0: 28 --> en:muscimol
    n1=en:anti-dyskinesia agents | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  56. en:anti-obesity agents --- r_associated #0: 28 --> en:muscimol
    n1=en:anti-obesity agents | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  57. en:cns stimulant --- r_associated #0: 28 --> en:muscimol
    n1=en:cns stimulant | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  58. en:oxazoles --- r_associated #0: 28 --> en:muscimol
    n1=en:oxazoles | n2=en:muscimol | rel=r_associated | relid=0 | w=28
  59. en:aflatoxin --- r_associated #0: 27 --> en:muscimol
    n1=en:aflatoxin | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  60. en:alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid --- r_associated #0: 27 --> en:muscimol
    n1=en:alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  61. en:antipyretics --- r_associated #0: 27 --> en:muscimol
    n1=en:antipyretics | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  62. en:gyromitrin --- r_associated #0: 27 --> en:muscimol
    n1=en:gyromitrin | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  63. en:muscarine --- r_associated #0: 27 --> en:muscimol
    n1=en:muscarine | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  64. en:neurotoxic mycotoxin --- r_associated #0: 27 --> en:muscimol
    n1=en:neurotoxic mycotoxin | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  65. toxines fongiques --- r_associated #0: 27 --> en:muscimol
    n1=toxines fongiques | n2=en:muscimol | rel=r_associated | relid=0 | w=27
  66. en:antidepressant agent --- r_associated #0: 26 --> en:muscimol
    n1=en:antidepressant agent | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  67. en:gaba agonists --- r_associated #0: 26 --> en:muscimol
    n1=en:gaba agonists | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  68. en:mechanism of action qualifier --- r_associated #0: 26 --> en:muscimol
    n1=en:mechanism of action qualifier | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  69. en:n,n-dimethylthiomuscimol --- r_associated #0: 26 --> en:muscimol
    n1=en:n,n-dimethylthiomuscimol | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  70. en:nootropic agents --- r_associated #0: 26 --> en:muscimol
    n1=en:nootropic agents | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  71. en:tenuazonic acid --- r_associated #0: 26 --> en:muscimol
    n1=en:tenuazonic acid | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  72. en:tremorgenic mycotoxin --- r_associated #0: 26 --> en:muscimol
    n1=en:tremorgenic mycotoxin | n2=en:muscimol | rel=r_associated | relid=0 | w=26
  73. en:alcohol deterrents --- r_associated #0: 25 --> en:muscimol
    n1=en:alcohol deterrents | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  74. en:antimanic agents --- r_associated #0: 25 --> en:muscimol
    n1=en:antimanic agents | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  75. en:methitural --- r_associated #0: 25 --> en:muscimol
    n1=en:methitural | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  76. en:oxadiazoles --- r_associated #0: 25 --> en:muscimol
    n1=en:oxadiazoles | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  77. en:phalloidine --- r_associated #0: 25 --> en:muscimol
    n1=en:phalloidine | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  78. en:potassium channel blockers --- r_associated #0: 25 --> en:muscimol
    n1=en:potassium channel blockers | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  79. en:t-2 toxin --- r_associated #0: 25 --> en:muscimol
    n1=en:t-2 toxin | n2=en:muscimol | rel=r_associated | relid=0 | w=25
  80. en:antitussive agent --- r_associated #0: 24 --> en:muscimol
    n1=en:antitussive agent | n2=en:muscimol | rel=r_associated | relid=0 | w=24
  81. en:trimethadione --- r_associated #0: 24 --> en:muscimol
    n1=en:trimethadione | n2=en:muscimol | rel=r_associated | relid=0 | w=24
  82. en:cytochalasins --- r_associated #0: 23 --> en:muscimol
    n1=en:cytochalasins | n2=en:muscimol | rel=r_associated | relid=0 | w=23
  83. en:amanitins --- r_associated #0: 22 --> en:muscimol
    n1=en:amanitins | n2=en:muscimol | rel=r_associated | relid=0 | w=22
  84. en:cns medications,other --- r_associated #0: 22 --> en:muscimol
    n1=en:cns medications,other | n2=en:muscimol | rel=r_associated | relid=0 | w=22
  85. antagoniste des opiacés --- r_associated #0: 21 --> en:muscimol
    n1=antagoniste des opiacés | n2=en:muscimol | rel=r_associated | relid=0 | w=21
  86. en:anguidine --- r_associated #0: 21 --> en:muscimol
    n1=en:anguidine | n2=en:muscimol | rel=r_associated | relid=0 | w=21
  87. en:antiparkinsonian agent --- r_associated #0: 21 --> en:muscimol
    n1=en:antiparkinsonian agent | n2=en:muscimol | rel=r_associated | relid=0 | w=21
  88. en:cycloserine --- r_associated #0: 21 --> en:muscimol
    n1=en:cycloserine | n2=en:muscimol | rel=r_associated | relid=0 | w=21
  89. en:ibotenic acid --- r_associated #0: 21 --> en:muscimol
    n1=en:ibotenic acid | n2=en:muscimol | rel=r_associated | relid=0 | w=21
  90. en:oxazolidinones --- r_associated #0: 21 --> en:muscimol
    n1=en:oxazolidinones | n2=en:muscimol | rel=r_associated | relid=0 | w=21
  91. Mycotoxines --- r_associated #0: 15 --> en:muscimol
    n1=Mycotoxines | n2=en:muscimol | rel=r_associated | relid=0 | w=15
  92. Mycotoxine --- r_associated #0: 10 --> en:muscimol
    n1=Mycotoxine | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  93. Psilocine --- r_associated #0: 10 --> en:muscimol
    n1=Psilocine | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  94. aflatoxine --- r_associated #0: 10 --> en:muscimol
    n1=aflatoxine | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  95. cyclosérine --- r_associated #0: 10 --> en:muscimol
    n1=cyclosérine | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  96. isocarboxazide --- r_associated #0: 10 --> en:muscimol
    n1=isocarboxazide | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  97. isoxazoles --- r_associated #0: 10 --> en:muscimol
    n1=isoxazoles | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  98. muscarine --- r_associated #0: 10 --> en:muscimol
    n1=muscarine | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  99. mycotique (anévrisme) --- r_associated #0: 10 --> en:muscimol
    n1=mycotique (anévrisme) | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  100. médicaments antipyrétiques --- r_associated #0: 10 --> en:muscimol
    n1=médicaments antipyrétiques | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  101. phalloïdine --- r_associated #0: 10 --> en:muscimol
    n1=phalloïdine | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  102. triméthadione --- r_associated #0: 10 --> en:muscimol
    n1=triméthadione | n2=en:muscimol | rel=r_associated | relid=0 | w=10
  103. agents antipyrétiques --- r_associated #0: 5 --> en:muscimol
    n1=agents antipyrétiques | n2=en:muscimol | rel=r_associated | relid=0 | w=5
  104. antipyrétiques --- r_associated #0: 5 --> en:muscimol
    n1=antipyrétiques | n2=en:muscimol | rel=r_associated | relid=0 | w=5
  105. oxazolidinones --- r_associated #0: 5 --> en:muscimol
    n1=oxazolidinones | n2=en:muscimol | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr